The program is still filling in: most podium sessions list one speaker so far, and 228 people on the speaker list have no session yet. We’ll add their talks and organizations as SLAS publishes them.

Rgenta Therapeutics at SLAS2027

Jan 30 – Feb 3, 2027 San Diego, CA ~7.6k attendees Website

Rgenta Therapeutics brings 1 presentation to SLAS2027 in San Diego. It develops oral small molecules that target RNA, first in cancer and neurological disorders. Its program is a part in the short course on genome editing and AI-driven approaches to drug discovery and target validation.

OrganizationSLAS2027 Attendance
rgentatx.com
Biopharma
Biotech developing oral small-molecule medicines that target RNA, first in cancer and neurological disorders.
Workshop
Sat Jan 30
8:30am–4:30pm
Genome Editing and AI-Driven Approaches in Drug Discovery and Target Validation
Room 8
Assay development and screening

Explore the full SLAS2027 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in San Diego. Leave your work email and we’ll be in touch.

Privacy

Download the full SLAS2027 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Rgenta Therapeutics

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with the Society for Laboratory Automation and Screening. Organization details are derived from SLAS’s published exhibitor list and event scheduler. Submit a correction